Other
FX Effect on Cash
Vertex Pharmaceuticals FX Effect on Cash increased by 278.0% to $7.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 115.4%, from -$47.30M to $7.30M. Over 3 years (FY 2021 to FY 2025), FX Effect on Cash shows an upward trend with a 89.3% CAGR.
Analysis
StatementCash Flow Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
Reflects global exposure; does not indicate operational performance but highlights the sensitivity of cash holdings to currency market volatility.
Detailed definition
Represents the impact of fluctuations in foreign currency exchange rates on the company's cash and cash equivalent balan...
Peer comparison
Standard for multinational corporations with significant international operations and cash holdings.
Metric ID:
cf_fx_effectHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.02M | -$8.46M | -$4.93M | -$5.90M | -$25.90M | -$38.20M | $12.00M | $10.00M | -$22.50M | $27.40M | -$15.60M | -$2.50M | $22.80M | -$47.30M | $30.50M | $57.20M | -$4.10M | $7.30M |
| QoQ Change | — | -310.5% | +41.8% | -19.7% | -339.0% | -47.5% | +131.4% | -16.7% | -325.0% | +221.8% | -156.9% | +84.0% | >999% | -307.5% | +164.5% | +87.5% | -107.2% | +278.0% |
| YoY Change | — | — | — | — | -744.4% | -351.5% | +303.4% | +138.6% | +41.1% | — | -230.0% | -125.0% | +201.3% | -272.6% | +295.5% | >999% | -118.0% | +115.4% |
Range-$47.30M – $57.20M
CAGR+15.1%
Avg YoY Growth+126.3%
Median YoY Growth+41.1%
FX Effect on Cash at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's fx effect on cash?
- Vertex Pharmaceuticals (VRTX) reported fx effect on cash of $7.30M in Q4 2025.
- How has Vertex Pharmaceuticals's fx effect on cash changed year-over-year?
- Vertex Pharmaceuticals's fx effect on cash increased by 115.4% year-over-year, from -$47.30M to $7.30M.
- What is the long-term trend for Vertex Pharmaceuticals's fx effect on cash?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's fx effect on cash has grown at a 89.3% compound annual growth rate (CAGR), from -$13.40M to $90.90M.
- What does fx effect on cash mean?
- The change in cash value caused by shifting foreign exchange rates.